LeonaBio (LONA) Current Leases (2020 - 2026)
LeonaBio's (LONA) quarterly Current Leases came in at $478000.0 in Q1 2026, up 12.21% year-on-year from $426000.0 in Q1 2025, and up 2.8% on a QoQ basis from $465000.0 in Q4 2025.
LeonaBio (LONA) Current Leases (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Current Leases data on file, last reported at $478000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 12.21% year-over-year to $478000.0 in Q1 2026; TTM through Mar 2026 was $478000.0, a 12.21% increase from a year earlier, with the FY2025 full-year figure at $465000.0, up 12.32% from the prior year.
- Current Leases for Q1 2026 stood at $478000.0, up from $465000.0 in the prior quarter.
- Over the last five years, Current Leases for LONA reached as high as $478000.0 in Q1 2026 and fell as low as $297000.0 in Q1 2022.
- Historically, Current Leases has averaged $382529.4 across 5 years, with a median of $380000.0 in 2024.
- Across the five-year window, Current Leases soared 48.5% in 2022 and advanced 12.11% in 2025, its largest moves.
- Year by year, Current Leases stood at $326000.0 in 2022, then gained by 12.88% to $368000.0 in 2023, then gained by 12.5% to $414000.0 in 2024, then grew by 12.32% to $465000.0 in 2025, then increased by 2.8% to $478000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $478000.0 in Q1 2026, $465000.0 in Q4 2025, and $452000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 478,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478,000.00 |
| Dec 31, 2025 | 465,000.00 |
| Sep 30, 2025 | 452,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 337,000.00 |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 307,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 279,000.00 |
| Jun 30, 2021 | 263,000.00 |